| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Wayne P. Rothbaum last filed a Form 4 in March 2024, as Director at IOVA. Wayne P. Rothbaum's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Wayne P. Rothbaum's trades have earned a middling insider score of 60/100 across 5 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +20.2%.
At the last filing, the largest reported position was 28,067,333 shares of IOVA. Net of sales, the IOVA filings show accumulation of 22,221,053 shares.
Wayne P. Rothbaum has 6 Form 4 filings on record from December 2018 to March 2024, all as Director at Iovance Biotherapeutics (IOVA), 2018–2024.
The 8 reported transactions were 7 open-market purchases and 1 option or other derivative award.
Counted by filing, the open-market trades come to 5 purchases worth about $156.3M and no sales.
The largest open-market purchase was 10,000,000 shares of IOVA at an average $6.50 on December 2, 2022, about $65.0M. Twelve months later IOVA was down 8%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 5,000,000 | $9.15 | $45,750,000.00 | +21.7% | -14.0% | -53.0% | |
| Sep 15, 2023 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 5,000,000 | $5.30 | $26,500,000.00 | +27.7% | +46.3% | +96.2% | |
| Dec 2, 2022 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 10,000,000 | $6.50 | $65,000,000.00 | +124.0% | +4.1% | -8.5% | |
| Jun 1, 2022 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 1,000,000 | $6.60 | $6,600,050.00 | +14.1% | +63.8% | +36.8% | |
| Dec 6, 2018 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 1,221,053 | $10.20 | $12,454,056.43 | +20.9% | - | - |